Cargando…

LMTK3 inhibition affects microtubule stability

Detalles Bibliográficos
Autores principales:	Cilibrasi, Chiara, Ditsiou, Angeliki, Papakyriakou, Athanasios, Mavridis, George, Eravci, Murat, Stebbing, Justin, Gagliano, Teresa, Giamas, Georgios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968321/ https://www.ncbi.nlm.nih.gov/pubmed/33731143 http://dx.doi.org/10.1186/s12943-021-01345-3

Ejemplares similares

Correction to: LMTK3 inhibition affects microtubule Stability
por: Cilibrasi, Chiara, et al.
Publicado: (2021)

The Inhibitory Properties of a Novel, Selective LMTK3 Kinase Inhibitor
por: Agnarelli, Alessandro, et al.
Publicado: (2023)

The structure-function relationship of oncogenic LMTK3
por: Ditsiou, Angeliki, et al.
Publicado: (2020)

LMTK3 confers chemo-resistance in breast cancer
por: Stebbing, Justin, et al.
Publicado: (2018)

Lemur tyrosine kinase-3 (LMTK3) in cancer and evolution
por: Stebbing, Justin, et al.
Publicado: (2011)

EGF and IGF1 affect sunitinib activity in BP-NEN: new putative targets beyond VEGFR?
por: Bresciani, Giulia, et al.
Publicado: (2019)

The multifaceted role of lemur tyrosine kinase 3 in health and disease
por: Ditsiou, Angeliki, et al.
Publicado: (2021)

Definition of an Inflammatory Biomarker Signature in Plasma-Derived Extracellular Vesicles of Glioblastoma Patients
por: Cilibrasi, Chiara, et al.
Publicado: (2022)

Reconstituting Immune Surveillance in Breast Cancer: Molecular Pathophysiology and Current Immunotherapy Strategies
por: Cilibrasi, Chiara, et al.
Publicado: (2021)

Extracellular Vesicles as Mediators of Therapy Resistance in the Breast Cancer Microenvironment
por: Samuels, Mark, et al.
Publicado: (2022)

Cancer gene therapy 2020: highlights from a challenging year
por: Giamas, Georgios, et al.
Publicado: (2021)

PDGF-R inhibition induces glioblastoma cell differentiation via DUSP1/p38(MAPK) signalling
por: Lane, Rosemary, et al.
Publicado: (2022)

The many-faced KSR1: a tumor suppressor in breast cancer
por: Zhang, Hua, et al.
Publicado: (2015)

Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy
por: Rani, Aradhana, et al.
Publicado: (2019)

Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma
por: Simon, Thomas, et al.
Publicado: (2018)

Hyperactive and impulsive behaviors of LMTK1 knockout mice
por: Takahashi, Miyuki, et al.
Publicado: (2020)

Proteome-wide dataset supporting functional study of tyrosine kinases in breast cancer
por: Angelopoulos, Nicos, et al.
Publicado: (2016)

The ERAP1 active site cannot productively access the N-terminus of antigenic peptide precursors stably bound onto MHC class I
por: Mavridis, George, et al.
Publicado: (2021)

LMTK1, a Novel Modulator of Endosomal Trafficking in Neurons
por: Hisanaga, Shin-ichi, et al.
Publicado: (2020)

Evaluation of Spheroid 3D Culture Methods to Study a Pancreatic Neuroendocrine Neoplasm Cell Line
por: Bresciani, Giulia, et al.
Publicado: (2019)

LMTK2 binds to kinesin light chains to mediate anterograde axonal transport of cdk5/p35 and LMTK2 levels are reduced in Alzheimer’s disease brains
por: Mórotz, Gábor M., et al.
Publicado: (2019)

Biological function of Lemur tyrosine kinase 2 (LMTK2): implications in neurodegeneration
por: Bencze, János, et al.
Publicado: (2018)

LMTK3 is essential for oncogenic KIT expression in KIT-mutant GIST and melanoma
por: Klug, Lillian R., et al.
Publicado: (2018)

Molecular screening and docking analysis of LMTK3and AKT1 combined inhibitors
por: Allam, Loubna, et al.
Publicado: (2018)

CircLMTK2 acts as a novel tumor suppressor in gastric cancer
por: He, Jian, et al.
Publicado: (2019)

LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway
por: Jiang, Tao, et al.
Publicado: (2020)

Proteomic profile of KSR1-regulated signalling in response to genotoxic agents in breast cancer
por: Zhang, Hua, et al.
Publicado: (2015)

Characterization of the Tyrosine Kinase-Regulated Proteome in Breast Cancer by Combined use of RNA interference (RNAi) and Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) Quantitative Proteomics
por: Stebbing, Justin, et al.
Publicado: (2015)

A Prediction Model Using Alternative Splicing Events and the Immune Microenvironment Signature in Lung Adenocarcinoma
por: Zhu, Liping, et al.
Publicado: (2021)

LMTK2-mediated Phosphorylation Regulates CFTR Endocytosis in Human Airway Epithelial Cells
por: Luz, Simão, et al.
Publicado: (2014)

LMTK3 knockdown retards cell growth and invasion and promotes apoptosis in thyroid cancer
por: Lu, Lu, et al.
Publicado: (2017)

Corrigendum to: LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway
Publicado: (2021)

Molecular recognition of N-acetyltryptophan enantiomers by β-cyclodextrin
por: Chatziefthimiou, Spyros D, et al.
Publicado: (2017)

ATG9A loss confers resistance to trastuzumab via c-Cbl mediated Her2 degradation
por: Nunes, Joao, et al.
Publicado: (2016)

A Pan-Cancer Analysis of SMARCA4 Alterations in Human Cancers
por: Peng, Ling, et al.
Publicado: (2021)

LMTK1 regulates dendritic formation by regulating movement of Rab11A-positive endosomes
por: Takano, Tetsuya, et al.
Publicado: (2014)

LMTK2 as Potential Biomarker for Stratification between Clinically Insignificant and Clinically Significant Prostate Cancer
por: Vezelis, Alvydas, et al.
Publicado: (2021)

Alterations in LMTK2, MSMB and HNF1B gene expression are associated with the development of prostate cancer
por: Harries, Lorna W, et al.
Publicado: (2010)

Knockdown of LMTK3 in the Endometrioid Adenocarcinoma Cell Line Ishikawa: Inhibition of Growth and Estrogen Receptor α
por: Cai, Guiyang, et al.
Publicado: (2021)

Neuropathological characterization of Lemur tyrosine kinase 2 (LMTK2) in Alzheimer’s disease and neocortical Lewy body disease
por: Bencze, János, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gkf3lekkia0dkhpba788o8dkpu